Granulocyte Colony-Stimulating Factor Utilization and Prescribing Patterns in Cancer Patients: A Single Institution Experience of a Saudi Cancer Center

Background Febrile neutropenia (FN), owing to its negative association with immune function and infectious complications, acts as a treatment-limiting factor in myelotoxic cancer chemotherapy. This study aimed to analyze the incidence of FN, utilization of granulocyte colony-stimulating factor (G-CS...

Descripción completa

Detalles Bibliográficos
Autores principales: Alyamani, Mohammad J, AlSalloum, Haya, Elgohary, Ghada, Alsaleh, Khalid, Abd El Warith, Ahmed, Abd El-Aziz, Nashwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387745/
https://www.ncbi.nlm.nih.gov/pubmed/35989759
http://dx.doi.org/10.7759/cureus.27017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387745/
https://www.ncbi.nlm.nih.gov/pubmed/35989759
http://dx.doi.org/10.7759/cureus.27017

Ejemplares similares